Page last updated: 2024-11-04

terbutaline and Alloxan Diabetes

terbutaline has been researched along with Alloxan Diabetes in 2 studies

Terbutaline: A selective beta-2 adrenergic agonist used as a bronchodilator and tocolytic.
terbutaline : A member of the class of phenylethanolamines that is catechol substituted at position 5 by a 2-(tert-butylamino)-1-hydroxyethyl group.

Research Excerpts

ExcerptRelevanceReference
" The effects of oxytocin in late pregnancy were also investigated."3.75Effects of experimentally induced diabetes mellitus on pharmacologically and electrically elicited myometrial contractility. ( Csík, G; Csonka, D; Falkay, G; Minorics, R; Spiegl, G; Zupkó, I, 2009)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19901 (50.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Spiegl, G1
Zupkó, I1
Minorics, R1
Csík, G1
Csonka, D1
Falkay, G1
Jansson, L1
Eizirik, DL1
Sandler, S1

Other Studies

2 other studies available for terbutaline and Alloxan Diabetes

ArticleYear
Effects of experimentally induced diabetes mellitus on pharmacologically and electrically elicited myometrial contractility.
    Clinical and experimental pharmacology & physiology, 2009, Volume: 36, Issue:9

    Topics: Adrenergic alpha-1 Receptor Agonists; Adrenergic beta-2 Receptor Agonists; Animals; Diabetes Mellitu

2009
Terbutaline decreases the blood flow of the pancreatic islets but does not reduce the diabetogenic action of streptozotocin in the rat.
    European journal of pharmacology, 1989, Feb-14, Volume: 161, Issue:1

    Topics: Animals; Blood Glucose; Diabetes Mellitus, Experimental; Insulin; Islets of Langerhans; Male; Rats;

1989